this work references cited by second hopReferences
- 2009Preferred reporting items for systematic reviews and meta-analyses: the PRISMA statement83,813 cited
- 1997Bias in meta-analysis detected by a simple, graphical test56,637 cited
- 1986Meta-analysis in clinical trials39,515 cited
- 1989The Yale-Brown Obsessive Compulsive Scale7,712 cited
- 1983A Fail-Safe N for Effect Size in Meta-Analysis2,065 cited
- 2008Practice Guideline for the Treatment of Patients With Obsessive-Compulsive Disorder1,028 cited
- 2008World Federation of Societies of Biological Psychiatry (WFSBP) Guidelines for the Pharmacological Treatment of Anxiety, Obsessive-Compulsive and Post-Traumatic Stress Disorders – First Revision860 cited
- 2014Evidence-based pharmacological treatment of anxiety disorders, post-traumatic stress disorder and obsessive-compulsive disorder: A revision of the 2005 guidelines from the British Association for Psychopharmacology676 cited
- 2006A systematic review: antipsychotic augmentation with treatment refractory obsessive-compulsive disorder635 cited
- 2000A Double-blind, Placebo-Controlled Study of Risperidone Addition in Serotonin Reuptake Inhibitor–Refractory Obsessive-compulsive Disorder571 cited
- 1994Haloperidol Addition in Fluvoxamine-Refractory Obsessive-Compulsive Disorder570 cited
- 2012Putting the efficacy of psychiatric and general medicine medication into perspective: review of meta-analyses451 cited
- 2012Guidelines for the pharmacological treatment of anxiety disorders, obsessive–compulsive disorder and posttraumatic stress disorder in primary care
Only edges whose both ends are imported exist here. Widen the year window, or show the whole map. Back to the work